204 related articles for article (PubMed ID: 20511555)
1. An autoantigen-specific, highly restricted T cell repertoire infiltrates the arthritic joints of mice in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Qian Z; Latham KA; Whittington KB; Miller DC; Brand DD; Rosloniec EF
J Immunol; 2010 Jul; 185(1):110-8. PubMed ID: 20511555
[TBL] [Abstract][Full Text] [Related]
2. T cell receptors recognizing type II collagen in HLA-DR-transgenic mice characterized by highly restricted V beta usage.
He X; Rosloniec EF; Myers LK; McColgan WL; Gumanovskaya M; Kang AH; Stuart JM
Arthritis Rheum; 2004 Jun; 50(6):1996-2004. PubMed ID: 15188377
[TBL] [Abstract][Full Text] [Related]
3. The impact of glycosylation on HLA-DR1-restricted T cell recognition of type II collagen in a mouse model.
von Delwig A; Altmann DM; Isaacs JD; Harding CV; Holmdahl R; McKie N; Robinson JH
Arthritis Rheum; 2006 Feb; 54(2):482-91. PubMed ID: 16447222
[TBL] [Abstract][Full Text] [Related]
4. Ex vivo characterization of the autoimmune T cell response in the HLA-DR1 mouse model of collagen-induced arthritis reveals long-term activation of type II collagen-specific cells and their presence in arthritic joints.
Latham KA; Whittington KB; Zhou R; Qian Z; Rosloniec EF
J Immunol; 2005 Apr; 174(7):3978-85. PubMed ID: 15778354
[TBL] [Abstract][Full Text] [Related]
5. Peptide-induced suppression of collagen-induced arthritis in HLA-DR1 transgenic mice.
Myers LK; Sakurai Y; Tang B; He X; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2002 Dec; 46(12):3369-77. PubMed ID: 12483744
[TBL] [Abstract][Full Text] [Related]
6. Induction of IL-10-producing CD4+CD25+ T cells in animal model of collagen-induced arthritis by oral administration of type II collagen.
Min SY; Hwang SY; Park KS; Lee JS; Lee KE; Kim KW; Jung YO; Koh HJ; Do JH; Kim H; Kim HY
Arthritis Res Ther; 2004; 6(3):R213-9. PubMed ID: 15142267
[TBL] [Abstract][Full Text] [Related]
7. Collagen type II (CII)-specific antibodies induce arthritis in the absence of T or B cells but the arthritis progression is enhanced by CII-reactive T cells.
Nandakumar KS; Bäcklund J; Vestberg M; Holmdahl R
Arthritis Res Ther; 2004; 6(6):R544-50. PubMed ID: 15535832
[TBL] [Abstract][Full Text] [Related]
8. Increased arthritis susceptibility in cartilage proteoglycan-specific T cell receptor-transgenic mice.
Berlo SE; Guichelaar T; Ten Brink CB; van Kooten PJ; Hauet-Broeren F; Ludanyi K; van Eden W; Broeren CP; Glant TT
Arthritis Rheum; 2006 Aug; 54(8):2423-33. PubMed ID: 16869010
[TBL] [Abstract][Full Text] [Related]
9. The influence of HLA-DR4 (0401) on the immune response to type II collagen and the development of collagen induced arthritis in mice.
Wang D; Hill JA; Cairns E; Bell DA
J Autoimmun; 2002 Mar; 18(2):95-103. PubMed ID: 11908942
[TBL] [Abstract][Full Text] [Related]
10. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
[TBL] [Abstract][Full Text] [Related]
11. Characterization of inhibitory T cells induced by an analog of type II collagen in an HLA-DR1 humanized mouse model of autoimmune arthritis.
Kimata M; Cullins DL; Brown ML; Brand DD; Rosloniec EF; Myers LK; Stuart JM; Kang AH
Arthritis Res Ther; 2012 May; 14(3):R107. PubMed ID: 22569209
[TBL] [Abstract][Full Text] [Related]
12. Induction of autoimmune arthritis in HLA-DR4 (DRB1*0401) transgenic mice by immunization with human and bovine type II collagen.
Rosloniec EF; Brand DD; Myers LK; Esaki Y; Whittington KB; Zaller DM; Woods A; Stuart JM; Kang AH
J Immunol; 1998 Mar; 160(6):2573-8. PubMed ID: 9510154
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of modified recombinant type II collagen in modulating autoimmune arthritis.
Myers LK; Tang B; Brand DD; Rosloniec EF; Stuart JM; Kang AH
Arthritis Rheum; 2004 Sep; 50(9):3004-11. PubMed ID: 15457470
[TBL] [Abstract][Full Text] [Related]
14. The neuroimmune semaphorin-3A reduces inflammation and progression of experimental autoimmune arthritis.
Catalano A
J Immunol; 2010 Nov; 185(10):6373-83. PubMed ID: 20937848
[TBL] [Abstract][Full Text] [Related]
15. Collagen-induced arthritis mediated by HLA-DR1 (*0101) and HLA-DR4 (*0401).
Rosloniec EF; Whittington KB; He X; Stuart JM; Kang AH
Am J Med Sci; 2004 Apr; 327(4):169-79. PubMed ID: 15084912
[TBL] [Abstract][Full Text] [Related]
16. Immunopathogenesis of collagen arthritis.
Brand DD; Kang AH; Rosloniec EF
Springer Semin Immunopathol; 2003 Aug; 25(1):3-18. PubMed ID: 12904888
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic autoreactive B cells are not negatively selected toward matrix protein collagen II.
Cao D; Khmaladze Ia; Jia H; Bajtner E; Nandakumar KS; Blom T; Mo JA; Holmdahl R
J Immunol; 2011 Nov; 187(9):4451-8. PubMed ID: 21940677
[TBL] [Abstract][Full Text] [Related]
18. Autoimmune regulator controls T cell help for pathogenetic autoantibody production in collagen-induced arthritis.
Campbell IK; Kinkel SA; Drake SF; van Nieuwenhuijze A; Hubert FX; Tarlinton DM; Heath WR; Scott HS; Wicks IP
Arthritis Rheum; 2009 Jun; 60(6):1683-93. PubMed ID: 19479827
[TBL] [Abstract][Full Text] [Related]
19. Acceleration of the onset of collagen-induced arthritis by a deficiency of platelet endothelial cell adhesion molecule 1.
Tada Y; Koarada S; Morito F; Ushiyama O; Haruta Y; Kanegae F; Ohta A; Ho A; Mak TW; Nagasawa K
Arthritis Rheum; 2003 Nov; 48(11):3280-90. PubMed ID: 14613294
[TBL] [Abstract][Full Text] [Related]
20. Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint.
Nissim A; Winyard PG; Corrigall V; Fatah R; Perrett D; Panayi G; Chernajovsky Y
Arthritis Rheum; 2005 Dec; 52(12):3829-38. PubMed ID: 16329077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
